Guadalquiver, Winsel .
HRN: 13-86-69 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/11/2024
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
12/11/2024
12/18/2024
PO
7ml
Q8h
Intestinal Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes